Jane Street
FLNA

Jane Street’s Filana Therapeutics FLNA Stock Holding History

Jane Street’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$139K Sell
82,300
-14,600
-15% -$30.1K ﹤0.01% 10448
2025
Q4 		$192K Sell
96,900
-300
-0.3% -$960 ﹤0.01% 9759
2025
Q3 		$283K Buy
97,200
+52,800
+119% +$121K ﹤0.01% 9024
2025
Q2 		$80.4K Sell
44,400
-65,300
-60% -$116K ﹤0.01% 9048
2025
Q1 		$165K Sell
109,700
-290,800
-73% -$734K ﹤0.01% 8581
2024
Q4 		$945K Buy
400,500
+89,900
+29% +$1.58M ﹤0.01% 5501
2024
Q3 		$9.14M Buy
310,600
+274,000
+749% +$6.31M ﹤0.01% 1999
2024
Q2 		$452K Sell
36,600
-34,400
-48% -$725K ﹤0.01% 7187
2024
Q1 		$1.43M Sell
71,000
-234,500
-77% -$5.4M ﹤0.01% 4740
2023
Q4 		$7.02M Buy
305,500
+135,700
+80% +$2.87M ﹤0.01% 2386
2023
Q3 		$2.83M Buy
169,800
+70,000
+70% +$1.39M ﹤0.01% 3462
2023
Q2 		$2.45M Sell
99,800
-91,400
-48% -$2.2M ﹤0.01% 3855
2023
Q1 		$4.61M Sell
191,200
-112,900
-37% -$3.13M ﹤0.01% 2571
2022
Q4 		$8.98M Sell
304,100
-269,900
-47% -$9.7M ﹤0.01% 1742
2022
Q3 		$24M Buy
574,000
+265,600
+86% +$7.17M 0.01% 924
2022
Q2 		$8.67M Buy
308,400
+33,400
+12% +$844K ﹤0.01% 1915
2022
Q1 		$10.2M Sell
275,000
-404,000
-59% -$17.1M ﹤0.01% 1963
2021
Q4 		$29.7M Sell
679,000
-520,300
-43% -$27.3M 0.01% 925
2021
Q3 		$74.5M Buy
1,199,300
+801,400
+201% +$66.9M 0.03% 439
2021
Q2 		$34M Buy
397,900
+23,800
+6% +$1.27M 0.01% 740
2021
Q1 		$16.8M Buy
374,100
+351,100
+1,527% +$13.8M 0.01% 1121
2020
Q4 		$157K Sell
23,000
-176,300
-88% -$1.57M ﹤0.01% 7061
2020
Q3 		$2.29M Buy
+199,300
New +$898K ﹤0.01% 2829

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Jane Street's FLNA Position: Q1 2026 in Review

Jane Street reduced its Filana Therapeutics (FLNA) stake by 56% in Q1 2026, selling an estimated $593K and leaving 225,164 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #8670.

Jane Street first reported a position in FLNA in Q2 2013 and has held it in 31 quarters since. The position peaked at $14.9M in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Jane Street held 225,164 shares of Filana Therapeutics worth $381K as of Q1 2026.
  • Jane Street sold 287,973 Filana Therapeutics shares in Q1 2026, an estimated $593K.
  • Filana Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8670 holding.
  • Jane Street first reported a position in Filana Therapeutics in Q2 2013 and has held it in 31 quarters since.
  • Jane Street's Filana Therapeutics position peaked at $14.9M in Q2 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.